BioCentury
ARTICLE | Company News

UCB sells U.S. generics unit to Lannett

September 4, 2015 1:08 AM UTC

UCB Group (Euronext:UCB) is selling U.S. generics subsidiary Kremers Urban Pharmaceuticals Inc. to Lannett Co. Inc. (NYSE:LCI) for $1.2 billion in cash. The parties expect the deal to close in 4Q15. L...